On ECHEMI
Home > Drugs > Lepu Pharmaceutical (Beijing) Co., Ltd.
Lepu Pharmaceutical (Beijing) Co., Ltd.
  • Founded in:

    1998-11-08
  • Country:

    China China
  • Address:

    Room 2032, Block B, No. 9 Chaoqian Road, Science and Technology Park, Changping District, Beijing
  • Tax NO.:

    91110114634394670K
  • Registered Funds:

    38.26666667 million yuan
  • Website:

  • Email:

Related Drugs
Ferrous Fumarate Tablets
This product contains ferrous fumarate
Name Description Content CAS NO. Registered Holders
Ferrous fumarate

Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.

More

Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.

141-01-5 14
Isosorbide Mononitrate Tablets
The main chemical name of this product is: 1,4:3,6-dianhydro-D-sorbitol-5-mononitrate.
Name Description Content CAS NO. Registered Holders
Isosorbide 5-mononitrate

It relaxes vascular smooth muscle and activates guanylate cyclase by releasing nitric oxide (NO), which increases cyclic guanosine monophosphate (cGMP) in smooth muscle cells, thereby dilating peripheral arteries and veins, reducing preload and afterload, increasing coronary artery perfusion, reducing myocardial oxygen consumption, and relieving angina pectoris.

More

It relaxes vascular smooth muscle and activates guanylate cyclase by releasing nitric oxide (NO), which increases cyclic guanosine monophosphate (cGMP) in smooth muscle cells, thereby dilating peripheral arteries and veins, reducing preload and afterload, increasing coronary artery perfusion, reducing myocardial oxygen consumption, and relieving angina pectoris.

16051-77-7 22
Fosfomycin calcium tablets
Name Description Content CAS NO. Registered Holders
Fosfomycin calcium

This product is a broad-spectrum antibiotic that inhibits the early synthesis of bacterial cell walls, causing bacterial cell wall synthesis to be inhibited and leading to their death. It has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and the antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.

More

This product is a broad-spectrum antibiotic that inhibits the early synthesis of bacterial cell walls, causing bacterial cell wall synthesis to be inhibited and leading to their death. It has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and the antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.

26472-47-9 5
Fosfomycin calcium tablets
Name Description Content CAS NO. Registered Holders
Fosfomycin calcium

This product is a broad-spectrum antibiotic that inhibits the early synthesis of bacterial cell walls, causing bacterial cell wall synthesis to be inhibited and leading to their death. It has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and the antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.

More

This product is a broad-spectrum antibiotic that inhibits the early synthesis of bacterial cell walls, causing bacterial cell wall synthesis to be inhibited and leading to their death. It has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and the antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.

26472-47-9 5
Cinnarizine Tablets
The main ingredients and chemical names of this product are: 1-diphenylmethyl-4-(3-phenyl-ethyl-propylene)-piperazine
Name Description Content CAS NO. Registered Holders
1-Benzhydryl-4-(3-phenyl-ethyl-propenyl)-piperazine

This product is a piperazine calcium channel antagonist that can block calcium influx into vascular smooth muscle, causing vasodilation and improving cerebral and coronary circulation, especially having a certain selective effect on cerebral blood vessels. This product can inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the intracellular cAMP concentration, inhibiting the release of histamine, 5-hydroxytryptamine, bradykinin and other biologically active substances, and also inhibiting the activation of complement C4.

More

This product is a piperazine calcium channel antagonist that can block calcium influx into vascular smooth muscle, causing vasodilation and improving cerebral and coronary circulation, especially having a certain selective effect on cerebral blood vessels. This product can inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the intracellular cAMP concentration, inhibiting the release of histamine, 5-hydroxytryptamine, bradykinin and other biologically active substances, and also inhibiting the activation of complement C4.

0
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.